N2 modified dinucleotide cap analogs as a potent tool for mRNA engineering

mRNA-based vaccines are relatively new technologies that have been in the field of interest of research centers and pharmaceutical companies in recent years. Such therapeutics are an attractive alternative for DNA-based vaccines since they provide material that can be used with no risk of genomic in...

Descripción completa

Detalles Bibliográficos
Autores principales: Grzela, Renata, Piecyk, Karolina, Stankiewicz-Drogon, Anna, Pietrow, Paulina, Lukaszewicz, Maciej, Kurpiejewski, Karol, Darzynkiewicz, Edward, Jankowska-Anyszka, Marzena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891257/
https://www.ncbi.nlm.nih.gov/pubmed/36418172
http://dx.doi.org/10.1261/rna.079460.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891257/
https://www.ncbi.nlm.nih.gov/pubmed/36418172
http://dx.doi.org/10.1261/rna.079460.122

Ejemplares similares